Drug Name Dosage Mechanism of Indication Contraindications Adverse Nursing Responsibilities

Action Reactions
Generic Dosage: Combivent For the Patients with CNS: Assessment and Drug
Name: Inhalation management cardiac lightheadedness, Effects:
100/20 mcg Solution is a of tachyarrhythmias, drowsiness,
Albuterol and per combination of bronchospasm hypertrophic insomnia, 1. Monitor
ipratropium actuation of the in patients obstructive dizziness, respiratory status;
inhaler the inhaler anticholinergic suffering cardiomyopathy vertigo, CNS auscultate lungs
bronchodilator, from chronic and patients with a stimulation before and after
Brand Name: Route: ipratropium obstructive history of inhalation
bromide, and pulmonary hypersensitivity to CV: 2. Report treatment
Combivent Inhalation the beta2- disease any of its hypertension, failure
neb Q8 adrenergic (COPD) who components or to arrhythmia, (exacerbation of
Frequency: bronchodilator, requires atropine or its hypotension, respiratory
Classification: salbutamol regular derivatives. tachycardia, symptoms) to
q6 hours sulfate. treatment angina physician
Bronchodilators Ipratropium with both
EENT: Patient and Family
bromide is a ipratropium
sinusitis, blurred Education:
quaternary and
vision, taste
ammonium salbutamol.
perversion, dry 1. Do not allow the
derivative of
mouth, solution/ mist to
atropine and is
paradoxical enter the eyes
an
bronchospasm,
anticholinergic
bronchitis 2. Consult a doctor
drug which has
immediately in the
bronchodilator GIT: event of acute,
properties. abdominal pain, rapidly worsening
Salbutamol dyspepsia, dyspnea. In
produces gastrointestinal addition, the
bronchodilation distress, patient should be
through vomiting, warned to seek
stimulation of diarrhea, medical advice
beta2- constipation should a reduced
adrenergic
response become
receptors in GUT: dysuria, apparent.
bronchial urinary
smooth muscle, retention, 3. The concomitant
thereby causing urinary use of Combivent
relaxation of difficulty with other
muscle fibres. sympathomimetic
This action is MS: Fatigue, agents is not
manifested by weakness recommended
an increase in since such
Others:
pulmonary combined use may
alopecia,
function as lead to deleterious
itching, rash,
demonstrated cardiovascular
flushing, ,
by spirometric effects.
edema
measurements.
4. Eye pain or
discomfort, blurred
vision, visual halos
or colored images
in association with
red eyes from
conjunctival and
corneal congestion
may be signs of
acute narrow-angle
glaucoma. Should
any combination of
these symptoms
develop, treatment
with miotic drops
should be initiated
and specialist
advice sought
immediately.

5. Allow 30-60 sec

between puffs for
 optimum results.

6. Wait 5 min
between this and
other inhaled
medications.

7. Rinse mouth after

medication puffs to
reduce bitter taste